Reporter

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.

The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC's Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.

Cathy Maxwell, PhD, Shelagh Mulvaney, PhD, and Bethany Rhoten, PhD, have been named Vanderbilt University School of Nursing’s first Valere Potter Distinguished Dean’s Faculty Fellows.

Kelly Brown, MD, associate professor of Clinical Neurology, will be assuming the role of executive medical director of the Neurosciences Patient Care Center (PCC) effective July 1.

Todd Peterson, PhD, associate professor of Radiology and Radiological Sciences, has been appointed director of the Vanderbilt University Institute of Imaging Science (VUIIS) Radiochemistry Core Lab, following the departure of Michael Nickels, PhD.

Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.

Have you ever wondered how Vanderbilt University School of Medicine recruits each year an outstanding class of future physician leaders and scientists? It is truly a team effort